← All news

FROM THE NEWS FEED

Will the FDA ever fast-track psychedelic drugs? 5 Questions with drug regulation expert Daniel Eisenkraft Klein

2026-03-09 • The Microdose (Berkeley)

Article summary

Eisenkraft Klein discusses the FDA’s new accelerated drug review program.

Continue to the original publication for the complete article.